Adiuvo Investments S.A. (ADV.WA)
PLN 0.36
(2.0%)
PLN 0.36
(2.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 990 Thousand PLN | 120.49% |
| 2022 | 449 Thousand PLN | -72.01% |
| 2021 | 1.6 Million PLN | 70.28% |
| 2020 | 942 Thousand PLN | -47.02% |
| 2019 | 1.77 Million PLN | -36.36% |
| 2018 | 2.79 Million PLN | -51.51% |
| 2017 | 5.76 Million PLN | 20.57% |
| 2016 | 4.77 Million PLN | 21.39% |
| 2015 | 3.93 Million PLN | 10836.11% |
| 2014 | 36 Thousand PLN | 0.0% |
| 2013 | - PLN | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | -60 Thousand PLN | -119.67% |
| 2024 Q1 | 305 Thousand PLN | -63.82% |
| 2023 Q3 | 48 Thousand PLN | 0.0% |
| 2023 Q4 | 843 Thousand PLN | 1656.25% |
| 2023 FY | 990 Thousand PLN | 120.49% |
| 2023 Q1 | 51 Thousand PLN | 383.33% |
| 2023 Q2 | 48 Thousand PLN | -5.88% |
| 2022 Q2 | 261 Thousand PLN | 150.96% |
| 2022 Q4 | -18 Thousand PLN | -117.65% |
| 2022 Q3 | 102 Thousand PLN | -60.92% |
| 2022 Q1 | 104 Thousand PLN | -90.71% |
| 2022 FY | 449 Thousand PLN | -72.01% |
| 2021 FY | 1.6 Million PLN | 70.28% |
| 2021 Q3 | 232 Thousand PLN | 190.0% |
| 2021 Q4 | 1.12 Million PLN | 382.76% |
| 2021 Q1 | 172 Thousand PLN | -67.24% |
| 2021 Q2 | 80 Thousand PLN | -53.49% |
| 2020 Q2 | 43 Thousand PLN | -76.76% |
| 2020 Q3 | 189 Thousand PLN | 339.53% |
| 2020 FY | 942 Thousand PLN | -47.02% |
| 2020 Q1 | 185 Thousand PLN | -68.1% |
| 2020 Q4 | 525 Thousand PLN | 177.78% |
| 2019 Q1 | 401 Thousand PLN | 26.9% |
| 2019 FY | 1.77 Million PLN | -36.36% |
| 2019 Q4 | 580 Thousand PLN | 40.44% |
| 2019 Q3 | 413 Thousand PLN | 7.55% |
| 2019 Q2 | 384 Thousand PLN | -4.24% |
| 2018 Q4 | 316 Thousand PLN | -69.17% |
| 2018 FY | 2.79 Million PLN | -51.51% |
| 2018 Q2 | 1.04 Million PLN | 34.32% |
| 2018 Q1 | 778 Thousand PLN | 463.77% |
| 2018 Q3 | 1.02 Million PLN | -1.91% |
| 2017 Q4 | 138 Thousand PLN | -86.79% |
| 2017 Q1 | 3.27 Million PLN | 58.9% |
| 2017 FY | 5.76 Million PLN | 20.57% |
| 2017 Q3 | 1.04 Million PLN | -19.86% |
| 2017 Q2 | 1.3 Million PLN | -60.18% |
| 2016 Q2 | 608 Thousand PLN | -63.98% |
| 2016 Q4 | 2.06 Million PLN | 388.39% |
| 2016 FY | 4.77 Million PLN | 21.39% |
| 2016 Q3 | 422 Thousand PLN | -30.59% |
| 2016 Q1 | 1.68 Million PLN | -26.96% |
| 2015 Q4 | 2.31 Million PLN | 303.32% |
| 2015 Q3 | 573 Thousand PLN | -39.81% |
| 2015 FY | 3.93 Million PLN | 10836.11% |
| 2015 Q2 | 952 Thousand PLN | 0.0% |
| 2015 Q1 | - PLN | 0.0% |
| 2014 Q1 | - PLN | 0.0% |
| 2014 Q2 | - PLN | 0.0% |
| 2014 Q3 | 36 Thousand PLN | 0.0% |
| 2014 Q4 | - PLN | -100.0% |
| 2014 FY | 36 Thousand PLN | 0.0% |
| 2013 FY | - PLN | 0.0% |
| 2013 Q4 | - PLN | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Genomtec S.A. | 1000.00 PLN | -98900.0% |
| Medinice S.A. | 225 Thousand PLN | -340.0% |
| Medicalgorithmics S.A. | 43.09 Million PLN | 97.703% |
| Synektik Spólka Akcyjna | 624.79 Million PLN | 99.842% |